CapsoVision Inc（CV）の株式分析

$5.870

+0.030 (+0.51%)終値時点

Loading chart…

High: 5.970
Open: 5.800
VWAP: 5.88
Vol: 62.22K
Mkt Cap: —
Low: 5.785
Amount: 365.51K
EV/EBITDA, TTM: -6.98

CapsoVision, Inc. is a global medical device innovator which specializes in diagnostic imaging of the gastrointestinal system. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.

www.capsovision.com

AI analysis of CapsoVision Inc (CV)

buy

CapsoVision Inc is a good buy right now, trading at $5.93 with a forward P/E of 0 and a gross margin of 51.36%. The recent 10% revenue growth in Q2 2026 and the positive analyst ratings suggest strong potential for recovery and growth. However, the main risk is the net income loss of $7.48 million in Q2 2026, which indicates ongoing financial challenges.

バリュエーション指標

The current forward P/E ratio for CapsoVision Inc (CV) is 0.00, compared to its 5-year average forward P/E of -10.86.

Forward P/E

Overvalued

5Y Average P/E

-10.86

Current P/E

0.00

割高

-5.23

割安

-16.50

Forward EV/EBITDA

Fair

5Y Average EV/EBITDA

-6.21

Current EV/EBITDA

-6.98

割高

-0.80

割安

-11.63

Forward P/S

Fair

5Y Average P/S

12.97

Current P/S

14.74

割高

20.00

割安

5.95

Alphio AI Price Scenarios for CV

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Bull

Bull · 25%CV

$5.79

シナリオ価格

Base

Base · 50%CV

$5.05

シナリオ価格

Bear

Bear · 25%CV

$4.89

シナリオ価格

イベントタイムライン

2026-08-27 (ET)